PlainRecalls
FDA Drug Moderate Class II Terminated

Metformin HCl Extended Release Tablets, USP, 500 mg, Generic for Glucophage XR, Pkg Size 100, Mfg: Time-Cap, Labs Inc., Farmingdale, NY, Preferred Pharmaceuticals, Anaheim, CA NDC: 68788-6932-01

Reported: July 8, 2020 Initiated: June 17, 2020 #D-1364-2020

Product Description

Metformin HCl Extended Release Tablets, USP, 500 mg, Generic for Glucophage XR, Pkg Size 100, Mfg: Time-Cap, Labs Inc., Farmingdale, NY, Preferred Pharmaceuticals, Anaheim, CA NDC: 68788-6932-01

Reason for Recall

CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.

Details

Units Affected
144 bottles
Distribution
Product was distributed to two medical clinics located in FL.
Location
Anaheim, CA

Frequently Asked Questions

What product was recalled?
Metformin HCl Extended Release Tablets, USP, 500 mg, Generic for Glucophage XR, Pkg Size 100, Mfg: Time-Cap, Labs Inc., Farmingdale, NY, Preferred Pharmaceuticals, Anaheim, CA NDC: 68788-6932-01. Recalled by Preferred Pharmaceuticals, Inc.. Units affected: 144 bottles.
Why was this product recalled?
CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 8, 2020. Severity: Moderate. Recall number: D-1364-2020.